Biogen licenses a stroke drug from Japanese drugmaker TMS
Bio Pharma Dive
MAY 12, 2021
The drug, which Biogen had an option to license, is one of two in the biotech's pipeline for a condition that has had few new treatments developed.
Bio Pharma Dive
MAY 12, 2021
The drug, which Biogen had an option to license, is one of two in the biotech's pipeline for a condition that has had few new treatments developed.
BioSpace
MAY 12, 2021
At the Seraph Research Institute, scientists presented new research at the 2021 ASGCT that shows promise in treating HIV.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MAY 12, 2021
The Advisory Committee on Immunization Practices is likely to recommend use of the shot among young teens after an FDA authorization earlier this week.
Scienmag
MAY 12, 2021
Credit: Rutgers University-New Brunswick New Brunswick, N.J. (May 12, 2021) – A Rutgers study finds that symbiotic bacteria that colonize root cells may be managed to produce hardier crops that need less fertilizer. The study appears in the journal Microorganisms. Bacteria stimulate root hair growth in all plants that form root hairs, so the researchers […].
Bio Pharma Dive
MAY 12, 2021
The future of provider and patient engagement in healthcare.
XTalks
MAY 12, 2021
National Nurses Week is celebrated every year to show appreciation to the nurses around the world. This year the celebrations begin on May 6 and end on May 12, and International Nurses Day is celebrated on May 12. The theme for this year’s nurse’s week is “Nurses: A Voice to Lead – A vision for future healthcare.” This week of appreciation sheds light on the power that nurses have in shaping the future of healthcare and transforming it to the next stage.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioPharma Reporter
MAY 12, 2021
Connectivity of unit operations is a key enabler for continuous manufacturing to deliver benefits of not only improved mass throughput, but ultimately reduced COGS and increased facility utilization, says Merck.
pharmaphorum
MAY 12, 2021
The care technology firm Birdie has raised $11.5 million to develop its app to help providers deliver elderly care at home. In a statement the UK firm said the fundraiser led by international VC Index Ventures and with participation from Kamet Ventures will be used to grow its business and develop its product. Birdie said its app can help care providers to efficiently deliver more coordinated, personalised and preventative care.
Druggist
MAY 12, 2021
Are you are one of few last patients who still get Celevac prescribed? Unfortunately, Celevac was discontinued , and now it is impossible to get it on prescription or purchase from the pharmacy. In this post, I will briefly review the use of Celevac,:what it is and talk about alternative options (prescription and over the counter products) which have similar use to Celevac.
XTalks
MAY 12, 2021
As the world plans its recovery from the setbacks imposed by the COVID-19 pandemic, industries are looking to apply lessons learned from the past year and improve business operations going forward. In the life sciences, like many industries, working from home will likely remain more prevalent than it was pre-pandemic even after it’s safe for employees to return to the office.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
MAY 12, 2021
Emergent company executives Fuad El-ibri and Robert Kramer will be testifying before a congressional probe after a botched batch of 15 million doses of J&J’s COVID-19 vaccine.
pharmaphorum
MAY 12, 2021
Biosimilars firm Alvotech has filed a lawsuit that challenges AbbVie’s legal defences surrounding the inflammatory disease drug Humira in the US. Alvotech is challenging the patent thicket surrounding Humira, a common ploy in pharma that seems to be particularly effective in the US. Several biological drugs have remained unchallenged on the US market thanks to a legal force-field from supplementary patents, after the main patent has expired and after protection has lapsed in Europe and other cou
Scienmag
MAY 12, 2021
Mutations can disrupt protein binding through a “burr effect” thus interfering with the regulation of cell growth Credit: Kümmel team/Oeckinghaus team Tuberous Sclerosis Complex (TSC) affects between one and two of every 10,000 new-born babies. This genetic disease leads to the formation of benign tumours which can massively impair the proper functioning of vital organs […].
BioSpace
MAY 12, 2021
Staying at home during the COVID-19 pandemic actually increased the spread of infection, according to new study published by the University of Chicago and, soon, by the National Bureau of Economic Research.
Scienmag
MAY 12, 2021
Credit: UM photo by Tommy Martino MISSOULA – Only an anthropologist would treasure millennia-old human feces found in dry caves. Just ask Dr. Meradeth Snow, a University of Montana researcher and co-chair of UM’s Department of Anthropology. She is part of an international team, led by the Harvard Medical School-affiliated Joslin Diabetes Center, that used […].
BioSpace
MAY 12, 2021
The moment you step on the job market, you’re selling yourself. Yes, you, the job seeker, are a “brand,” and each touchpoint you have with a potential new employer is an opportunity to “sell” that brand, that vision of your candidacy, the promise of yourself as a future team member and employer.
Scienmag
MAY 12, 2021
A recently discovered letter written by Albert Einstein discusses a link between physics and biology, seven decades before evidence emerges. Credit: Dyer et al. 2021, J Comp Physiol A / The Hebrew University of Jerusalem The 1949 letter by the physicist and Nobel laureate discusses bees, birds and whether new physics principles could come from […].
BioSpace
MAY 12, 2021
Comments on social media provide a glimpse at the deep divide in trust of public health agencies, and now a new survey demonstrates the breadth of that distrust.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
MAY 12, 2021
NICE has rejected regular NHS funding for Pfizer’s Vyndaqel (tafamidis) for a rare heart condition, although it has left the door open for negotiations if the pharma decides to drop its price. Pfizer had appealed against draft guidance from NICE that rejected Vyndaqel for transthyretin amyloidosis with cardiomyopathy (ATTR-CM) on cost grounds. The pharma unsuccessfully appealed against the decision in first draft guidance issued in June last year, along with patient associations Cardiomyopathy U
BioSpace
MAY 12, 2021
Aphios International is developing a generally applicable pathogen reduction technology for pooled blood plasma and blood products, immunoglobulins, recombinant biologics and monoclonal antibodies used to treat cancer and COVID-19 patients.
Scienmag
MAY 12, 2021
FDA grant supports use of real-world data to generate real-world evidence in neonates Credit: C-Path TUCSON, Ariz., May 12, 2021 — Critical Path Institute (C-Path) and Tufts Medical Center have announced a joint venture to integrate the first patient-level clinical trial data to generate actionable real-world evidence (RWE) for neonatal drug development, from real-world neonate […].
BioSpace
MAY 12, 2021
SpliSense, which focuses on cystic fibrosis and other genetic pulmonary diseases, closed on a $28.5 million Series B financing round. The company plans to use the money to advance its pipeline.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
MAY 12, 2021
IQVIA’s Liz Murray takes us through the company’s latest research into HCPs’ attitudes to pharma engagement, and asks how pharma sales forces can adapt for future changes. This article appears in full in Deep Dive: Market Access 2021. Read a preview below: Recent ChannelDynamics data from IQVIA shows that while there has been a marked positive change in HCPs’ views of remote rep platforms over the past 12 months, there has not actually been much change in their views of face-to-face engagement,
Scienmag
MAY 12, 2021
Mapping culture and climatic energy drivers in Europe Credit: Cultural-E project Researchers from RMIT University, Eurac Research and University Ca’ Foscari Venezia have launched an innovative GIS map with a difference: The European Climate and Cultural Atlas for Plus Energy Building Design – the 2CAP-Energy Atlas. The Atlas has been developed as part of the […].
Pharma Times
MAY 12, 2021
The final guidance publication comes following an appeal against earlier draft recommendations
Scienmag
MAY 12, 2021
Polypharmakos Limited, a spin-out company from the Royal Botanic Gardens Kew and University of Cambridge, and international not-for-profit organisation CABI have signed a research collaboration and licensing agreement to develop novel products from Credit: CABI Polypharmakos Limited, a spin-out company from the UK’s Royal Botanic Gardens Kew and University of Cambridge, and international not-for-profit organisation […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Pharma Times
MAY 12, 2021
Pharma industry and health leaders react to new legislation and plans outlined in the Queen’s Speech
Scienmag
MAY 12, 2021
Alexandria, Va., USA — COVID-19 was declared a global pandemic in March 2020 and given an incomplete understanding of the transmission of SARS-CoV-2 at that time, the American Dental Association recommended that dental offices refrain from providing non-emergency services. As a result, 198,000 dentists in the United States closed their doors to patients.
pharmaphorum
MAY 12, 2021
UK biotech MiNA Therapeutics has signed up another big pharma partner for its small activating RNA (saRNA) platform, which upregulates the activity of proteins, with Eli Lilly the latest to get in on the action. . While most RNA-based drugs are intended to reduce the activity of proteins that are over-expressed, saRNAs work in the opposite way, amplifying the expression of proteins which are not produced in sufficient amounts.
Scienmag
MAY 12, 2021
Scientists at TU Darmstadt develop adaptive font that speeds up reading AdaptiFont has recently been presented at CHI, the leading Conference on Human Factors in Computing. Language is without doubt the most pervasive medium for exchanging knowledge between humans. However, spoken language or abstract text need to be made visible in order to be read, […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Let's personalize your content